NBAS p.Val842Phe
c.2524G>T · rs1085307944 · VCV427078
Computational evidence
| Protein change | ||
| AlphaMissense | 0.4124 | ambiguous |
|---|---|---|
| REVEL | 0.181 | moderately benign-leaning |
| SaProt | LLR -7.78 | tolerated |
| ⇒ REVEL and SaProt both call this tolerated; AlphaMissense is indeterminate. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 1.7, phastCons 0.94 |
| Regional constraint | o/e 1.03 | unconstrained · MANE · 394 kb · p 0.09 · regional, not allelic |
| Overall | ||
| CADD | 24.2 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,242 |
| European (non-Finnish)grpmax | 0.00144% | 69,412 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NBAS
- Protein
- p.Val842Phe
- Coding
- c.2524G>T
- MANE Select
- NM_015909
- dbSNP
- rs1085307944
- Type
- single nucleotide variant
- Location
- chr2:15424368 (GRCh38)
- Gene constraint
- LOEUF 0.761 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 74.42
- Residue 842
- a UniProt-annotated variant site (in ilfs2; uncertain significance); a UniProt-annotated variant site (found in a patient with a multisystem disease involving liver, eye, immune system, connective tissue and bone; uncertain significance); a UniProt-annotated variant site (found in a patient with a multisystem disease involving liver, eye, immune system, connective tissue and bone; uncertain significance; reduced protein expression levels in fibroblasts); a UniProt-annotated variant site (in ilfs2); the 'interaction with use1' region
Disease context
infantile liver failure syndrome 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Fever-associated acute infantile liver failure syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy
Similar variants
- NBAS c.173-2A>G Likely pathogenic ★★ same condition
- NBAS c.2423+404G>C Likely pathogenic ★★ same condition
- NBAS c.4583-2A>G Likely pathogenic ★★ same condition
- NBAS c.513+2T>C Pathogenic/Likely pathogenic ★★ same condition
- NBAS p.Arg1004Ter Pathogenic ★★ same condition
- NBAS p.Arg1236Ter Pathogenic/Likely pathogenic ★★ same condition
- NBAS p.Arg136Gly Likely pathogenic ★★ same condition
- NBAS p.Arg137Trp Pathogenic/Likely pathogenic ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nbas-p-val842phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown